• Home
  •  / Cello Health

Cello Health

OverviewSuggest Edit

Cello Health (formerly known as Cello Group) is a company which provides marketing services mainly to the pharmaceutical and health sectors. It operates through two segments, such as Cello Health and Cello Signal. The Company also offers market research and consulting services.
TypePublic
Founded2004
HQLondon, GBMap
Websitecellohealthplc.com
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Jun 2017)1,000(+7%)
Revenue (FY, 2018)£165.6 M(-2%)
Share Price (Aug 2020)£1.6
Cybersecurity ratingAMore

Key People/Management at Cello Health

Chris Jones

Chris Jones

Independent Non-Executive Chairman
Stephen Highley

Stephen Highley

Group Chief Operating Officer & Director
Mark Scott

Mark Scott

Chief Executive Officer & Director
Julia Ralston

Julia Ralston

hief Executive Officer, Cello Health Inc. & Director
Mark Bentley

Mark Bentley

Group Finance Director
Clifford Tompsett

Clifford Tompsett

Senior Independent Non-Executive Director
Show more

Cello Health Office Locations

Cello Health has an office in London
London, GB (HQ)
House 8, Golden Fleece, 9 Queen St
Show all (1)

Cello Health Financials and Metrics

Cello Health Revenue

Embed Graph
View revenue for all periods
Cello Health's revenue was reported to be £165.57 m in FY, 2018 which is a 2.8% decrease from the previous period.
GBP

Revenue (FY, 2018)

165.6m

Revenue growth (FY, 2017 - FY, 2018), %

(2.8%)

Gross profit (FY, 2018)

104.8m

Gross profit margin (FY, 2018), %

63.3%

Net income (FY, 2018)

6.6m

EBITDA (FY, 2018)

11.0m

EBIT (FY, 2018)

8.8m

Market capitalization (11-Aug-2020)

178.8m

Closing stock price (11-Aug-2020)

1.6

Cash (31-Dec-2018)

10.4m
Cello Health's current market capitalization is £178.8 m.
GBPFY, 2016FY, 2017FY, 2018

Revenue

165.3m170.3m165.6m

Revenue growth, %

5%3%(3%)

Cost of goods sold

72.6m67.8m60.8m

Gross profit

92.7m102.5m104.8m
show all
GBPFY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

9.7m6.7m7.0m7.0m5.1m3.1m797.0k4.2m4.1m6.0m5.6m5.2m7.5m13.0m10.4m

Accounts Receivable

7.4m8.9m14.6m21.3m19.8m19.0m20.0m21.6m23.8m28.5m29.9m40.3m43.3m36.4m35.3m

Inventories

5.6m604.0k928.0k

Current Assets

24.2m18.8m26.6m35.7m31.7m28.8m27.2m33.3m34.1m42.3m45.6m48.9m54.3m65.0m58.3m
show all
GBPFY, 2004FY, 2005FY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

859.0k2.9m3.0m3.1m3.2m(6.0m)3.6m(334.0k)156.0k3.6m2.3m3.3m(2.5m)4.2m6.6m

Cash From Operating Activities

3.0m5.7m4.2m5.9m7.8m4.6m7.1m5.8m6.1m9.3m2.4m7.0m4.9m2.7m11.2m

Dividends Paid

131.0k382.0k556.0k733.0k814.0k709.0k1.4m1.6m2.6m2.2m2.6m3.6m3.7m

Cash From Financing Activities

13.8m1.1m3.5m2.5m(5.1m)(4.3m)(7.7m)1.4m(1.1m)(5.3m)13.0k(6.1m)(836.0k)10.2m(11.7m)
show all
GBPFY, 2004

Financial Leverage

1.8 x
Show all financial metrics

Cello Health Cybersecurity Score

Cybersecurity ratingPremium dataset

A

98/100

Learn more about our premium products
SecurityScorecard logo

Cello Health Online and Social Media Presence

Cello Health's Trends

Embed Graph

Cello Health News and Updates

August 11, 2020

Arsenal Capital Partners Completes £182 Million Acquisition of Cello Health

NEW YORK, Aug. 11, 2020 /PRNewswire/ – Arsenal Capital Partners ("Arsenal"), a specialized private equity firm investing in healthcare and industrials companies, has completed the acquisition of Cello Health plc ("Cello Health"), the global healthcare-focused advisory firm, for a total...
July 01, 2020

Form 8.3 - Cello Health plc

FORM 8.3

Cello Health Blogs

August 11, 2020

Scheme of Arrangement Becomes Effective

Cash Acquisition of Cello Health plc The post Scheme of Arrangement Becomes Effective appeared first on Cello Health plc.
August 11, 2020

Suspension – Cello Health plc

Suspension of trading on AIM The post Suspension – Cello Health plc appeared first on Cello Health plc.
August 10, 2020

Relevant Securities in Issue

Ordinary share allocation The post Relevant Securities in Issue appeared first on Cello Health plc.
August 10, 2020

Exercise of Options

Options exercised by persons discharging managerial responsibilities The post Exercise of Options appeared first on Cello Health plc.
August 07, 2020

Court Sanction of Scheme

Court Order sanction issued The post Court Sanction of Scheme appeared first on Cello Health plc.
August 07, 2020

Additional Block Listing of Ordinary Shares

Application for 2,421,000 new ordinary shares The post Additional Block Listing of Ordinary Shares appeared first on Cello Health plc.
Show more

 Cello Health Frequently Asked Questions

  • When was Cello Health founded?

    Cello Health was founded in 2004.

  • Who are Cello Health key executives?

    Cello Health's key executives are Chris Jones, Stephen Highley and Mark Scott.

  • How many employees does Cello Health have?

    Cello Health has 1,000 employees.

  • What is Cello Health revenue?

    Latest Cello Health annual revenue is £165.6 m.

  • What is Cello Health revenue per employee?

    Latest Cello Health revenue per employee is £165.6 k.

  • Who are Cello Health competitors?

    Competitors of Cello Health include Red Ventures, Siemens Digital Industries Software and Otsuka.

  • Where is Cello Health headquarters?

    Cello Health headquarters is located at House 8, Golden Fleece, 9 Queen St, London.

  • Where are Cello Health offices?

    Cello Health has an office in London.

  • How many offices does Cello Health have?

    Cello Health has 1 office.